000287407 001__ 287407
000287407 005__ 20241111182444.0
000287407 0247_ $$2doi$$a10.3390/cancers16020439
000287407 0247_ $$2pmid$$apmid:38275880
000287407 0247_ $$2pmc$$apmc:PMC10814462
000287407 037__ $$aDKFZ-2024-00222
000287407 041__ $$aEnglish
000287407 082__ $$a610
000287407 1001_ $$0P:(DE-He78)2677283989b003b29849ae4121bda5ff$$aBarbosa, Silvia$$b0$$eFirst author
000287407 245__ $$aThe Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence.
000287407 260__ $$aBasel$$bMDPI$$c2024
000287407 3367_ $$2DRIVER$$aarticle
000287407 3367_ $$2DataCite$$aOutput Types/Journal article
000287407 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1706532237_23420
000287407 3367_ $$2BibTeX$$aARTICLE
000287407 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000287407 3367_ $$00$$2EndNote$$aJournal Article
000287407 500__ $$a#EA:E220#LA:E220#LA:E221#
000287407 520__ $$aHead and neck squamous cell carcinoma (HNSCC) exhibits considerable variability in patient outcome. It has been reported that SOX2 plays a role in proliferation, tumor growth, drug resistance, and metastasis in a variety of cancer types. Additionally, SOX9 has been implicated in immune tolerance and treatment failures. SOX2 and SOX9 induce treatment failure by a molecular mechanism that has not yet been elucidated. This study explores the inverse association of SOX2/SOX9 and their distinct expression in tumors, influencing the tumor microenvironment and radiotherapy responses. Through public RNA sequencing data, human biopsy samples, and knockdown cellular models, we explored the effects of inverted SOX2 and SOX9 expression. We found that patients expressing SOX2LowSOX9High showed decreased survival compared to SOX2HighSOX9Low. A survival analysis of patients stratified by radiotherapy and human papillomavirus brings additional clinical relevance. We identified a gene set signature comprising newly discovered candidate genes resulting from inverted SOX2/SOX9 expression. Moreover, the TGF-β pathway emerges as a significant predicted contributor to the overexpression of these candidate genes. In vitro findings reveal that silencing SOX2 enhances tumor radioresistance, while SOX9 silencing enhances radiosensitivity. These discoveries lay the groundwork for further studies on the therapeutic potential of transcription factors in optimizing HNSCC treatment.
000287407 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000287407 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000287407 650_7 $$2Other$$aHNSCC
000287407 650_7 $$2Other$$aHPV negative
000287407 650_7 $$2Other$$aSOX2
000287407 650_7 $$2Other$$aSOX9
000287407 650_7 $$2Other$$agene set signature
000287407 650_7 $$2Other$$ametastasis
000287407 650_7 $$2Other$$aradiation treatment
000287407 7001_ $$00000-0002-9587-2842$$aLaureano, Natalia Koerich$$b1
000287407 7001_ $$0P:(DE-He78)f3a873e7ab94ef36c11fcf1023c8d860$$aHadiwikarta, Wahyu Wijaya$$b2$$udkfz
000287407 7001_ $$00000-0002-4033-8431$$aVisioli, Fernanda$$b3
000287407 7001_ $$0P:(DE-He78)dfbd048cb771a09543aad8eba5013468$$aBonrouhi, Mahnaz$$b4$$udkfz
000287407 7001_ $$aPajdzik, Kinga$$b5
000287407 7001_ $$00000-0001-9928-790X$$aConde-Lopez, Cristina$$b6
000287407 7001_ $$aHerold-Mende, Christel$$b7
000287407 7001_ $$0P:(DE-He78)0b3d1b5bf06d3d407258e0e93c1b515b$$aEidt, Gustavo$$b8
000287407 7001_ $$00000-0001-6249-2862$$aLangie, Renan$$b9
000287407 7001_ $$00000-0001-5296-5662$$aLamers, Marcelo Lazzaron$$b10
000287407 7001_ $$00000-0002-8897-5165$$aStögbauer, Fabian$$b11
000287407 7001_ $$aHess, Jochen$$b12
000287407 7001_ $$0P:(DE-He78)f3723bca6eb95009d4c95a7590617b68$$aKurth, Ina$$b13$$eLast author$$udkfz
000287407 7001_ $$00000-0001-9684-3093$$aJou, Adriana$$b14$$eLast author
000287407 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers16020439$$gVol. 16, no. 2, p. 439 -$$n2$$p439$$tCancers$$v16$$x2072-6694$$y2024
000287407 8564_ $$uhttps://inrepo02.dkfz.de/record/287407/files/cancers-16-00439.pdf
000287407 8564_ $$uhttps://inrepo02.dkfz.de/record/287407/files/cancers-16-00439.pdf?subformat=pdfa$$xpdfa
000287407 8767_ $$82776517$$92024-01-13$$d2024-11-11$$eAPC$$jZahlung erfolgt$$pcancers-2776517
000287407 909CO $$ooai:inrepo02.dkfz.de:287407$$pVDB$$pOpenAPC$$popenCost
000287407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2677283989b003b29849ae4121bda5ff$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-9587-2842$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f3a873e7ab94ef36c11fcf1023c8d860$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)dfbd048cb771a09543aad8eba5013468$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-9928-790X$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0b3d1b5bf06d3d407258e0e93c1b515b$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-6249-2862$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f3723bca6eb95009d4c95a7590617b68$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000287407 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-9684-3093$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000287407 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000287407 9141_ $$y2024
000287407 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-07-31T16:07:06Z
000287407 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-07-31T16:07:06Z
000287407 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-07-31T16:07:06Z
000287407 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-07-31T16:07:06Z
000287407 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000287407 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000287407 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000287407 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000287407 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
000287407 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
000287407 9202_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie Radiobiologie$$x0
000287407 9202_ $$0I:(DE-He78)E221-20160331$$kE221$$lMolekulare Grundlagen von HNO-Tumoren$$x1
000287407 9201_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie Radiobiologie$$x0
000287407 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000287407 9201_ $$0I:(DE-He78)E221-20160331$$kE221$$lMolekulare Grundlagen von HNO-Tumoren$$x2
000287407 9200_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie Radiobiologie$$x0
000287407 980__ $$ajournal
000287407 980__ $$aVDB
000287407 980__ $$aI:(DE-He78)E220-20160331
000287407 980__ $$aI:(DE-He78)HD01-20160331
000287407 980__ $$aI:(DE-He78)E221-20160331
000287407 980__ $$aUNRESTRICTED
000287407 980__ $$aAPC